Nutraceuticals and polycystic ovary syndrome: a systematic review of the literature

References

• Sirmans S, Pate K. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1–13.
   PubMed Web of Science ®Google Scholar
• Wehr E, Pilz S, Schweighofer N, et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol. 2009;161(4):575–582.
   PubMed Web of Science ®Google Scholar
• Menichini D, Facchinetti F. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review. Gynecol Endocrinol. 2020;36(1):1–5.
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47.
   PubMed Web of Science ®Google Scholar
• Angellotti E, D’Alessio D, Dawson-Hughes B, et al. Vitamin D supplementation in patients with type 2 diabetes: the vitamin D for established type 2 diabetes (DDM2) study. J Endocr Soc. 2018;2(4):310–321.
   PubMed Web of Science ®Google Scholar
• Ota K, Dambaeva S, Kim MW-I, et al. 1,25-Dihydroxy-vitamin D3 regulates NK-cell cytotoxicity, cytokine secretion, and degranulation in women with recurrent pregnancy losses. Eur J Immunol. 2015;45(11):3188–3199.
   PubMed Web of Science ®Google Scholar
• Monastra G, De Grazia S, De Luca L, et al. Vitamin D: a steroid hormone with progesterone-like activity. Eur Rev Med Pharmacol Sci. 2018;22(8):2502–2512.
   PubMed Web of Science ®Google Scholar
• Bender Atik R, Christiansen OB, Elson J, et al. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2018;2018(2):hoy004.
   PubMedGoogle Scholar
• Gupta T, Rawat M, Gupta N, et al. Study of effect of vitamin D supplementation on the clinical, hormonal and metabolic profile of the PCOS women. J Obstet Gynecol India. 2017;67(5):349–355.
   PubMed Web of Science ®Google Scholar
• Kadoura S, Alhalabi M, Nattouf AH. Effect of calcium and vitamin D supplements as an adjuvant therapy to metformin on menstrual cycle abnormalities, hormonal profile, and IGF-1 system in polycystic ovary syndrome patients: a randomized, placebo-controlled clinical trial. Adv Pharmacol Sci. 2019;2019:9680390–9680310.
   PubMed Web of Science ®Google Scholar
• Javed Z, Papageorgiou M, Deshmukh H, et al. A randomized, controlled trial of vitamin D supplementation on cardiovascular risk factors, hormones, and liver markers in women with polycystic ovary syndrome. Nutrients. 2019;11(1):188.
   Web of Science ®Google Scholar
• Trummer C, Schwetz V, Kollmann M, et al. Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial. Eur J Nutr. 2019;58(5):2019–2028.
   PubMed Web of Science ®Google Scholar
• Dastorani M, Aghadavod E, Mirhosseini N, et al. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization. Reprod Biol Endocrinol. 2018;16(1):94.
   PubMedGoogle Scholar
• Ostadmohammadi V, Jamilian M, Bahmani F, et al. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome. J Ovarian Res. 2019;12(1):5.
   PubMedGoogle Scholar
• Ciepiela P, Dulęba AJ, Kowaleczko E, et al. Vitamin D as a follicular marker of human oocyte quality and a serum marker of in vitro fertilization outcome. J Assist Reprod Genet. 2018;35(7):1265–1276.
   PubMed Web of Science ®Google Scholar
• Laganà AS, Vitale SG, Ban Frangež H, et al. Vitamin D in human reproduction: the more, the better? An evidence-based critical appraisal. Eur Rev Med Pharmacol Sci. 2017;21(18):4243–4251. http://www.ncbi.nlm.nih.gov/pubmed/29028072
   PubMed Web of Science ®Google Scholar
• Viganò P, Lattuada D, Mangioni S, et al. Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol. 2006;36(3):415–424.
   PubMed Web of Science ®Google Scholar
• Bezerra Espinola MS, Bilotta G, Aragona C. Positive effect of a new supplementation of vitamin D3 with myo-inositol, folic acid and melatonin on IVF outcomes: a prospective randomized and controlled pilot study. Gynecol Endocrinol. 2021;37(3):251–254.
   PubMed Web of Science ®Google Scholar
• Monteagudo-Mera A, Rastall RA, Gibson GR, et al. Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health. Appl Microbiol Biotechnol. 2019;103(16):6463–6472.
   PubMed Web of Science ®Google Scholar
• Nasri K, Jamilian M, Rahmani E, et al. The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. BMC Endocr Disord. 2018;18(1):21.
   PubMedGoogle Scholar
• Jamilian M, Mansury S, Bahmani F, et al. The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome. J Ovarian Res. 2018;11(1):80.
   PubMed Web of Science ®Google Scholar
• Zhao X, Jiang Y, Xi H, et al. Exploration of the relationship between gut microbiota and polycystic ovary syndrome (PCOS): a review. Geburtshilfe Frauenheilkd. 2020;80(2):161–171.
   PubMed Web of Science ®Google Scholar
• He F-F, Li Y-M. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J Ovarian Res. 2020;13(1):73.
   PubMed Web of Science ®Google Scholar
• Karamali M, Eghbalpour S, Rajabi S, et al. Effects of probiotic supplementation on hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, Double-Blind, Placebo-Controlled trial. Arch Iran Med. 2018;21(1):1–7. http://www.ncbi.nlm.nih.gov/pubmed/29664663
   PubMed Web of Science ®Google Scholar
• Askari G, Shoaei T, Tehrani H, et al. Effects of probiotic supplementation on pancreatic β-cell function and c-reactive protein in women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Int J Prev Med. 2015;6(1):27.
   PubMedGoogle Scholar
• Chen J, Guo Q, Pei Y, et al. Effect of a short-term vitamin E supplementation on oxidative stress in infertile PCOS women under ovulation induction: a retrospective cohort study. BMC Womens Health. 2020;20(1):69.
   PubMed Web of Science ®Google Scholar
• Izadi A, Ebrahimi S, Shirzai S, et al. Hormonal and metabolic effects of coenzyme Q10 and/or vitamin E in patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2019;104(2):319–327
   PubMed Web of Science ®Google Scholar
• Talari HR, Poladchang S, Hamidian Y, et al. The effects of omega-3 and vitamin E Co-supplementation on carotid intima-media thickness and inflammatory factors in patients with polycystic ovary syndrome. Oman Med J. 2018;33(6):473–480.
   PubMedGoogle Scholar
• Menichini D, Alrais M, Liu C, Xia Y, Blackwell SC, Facchinetti F, Sibai BM, Longo M. Maternal supplementation of inositols, fucoxanthin, and hydroxytyrosol in pregnant murine models of hypertension. Am J Hypertens. 2020;33(7):652–659.
   PubMed Web of Science ®Google Scholar
• Dinicola S, Unfer V, Facchinetti F, et al. Inositols: from established knowledge to novel approaches. IJMS. 2021;22(19):10575.
   Google Scholar
• Showell MG, Mackenzie-Proctor R, Jordan V, et al. Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2018;12(12):CD012378.
   PubMedGoogle Scholar
• Montanino Oliva M, Buonomo G, Calcagno M, et al. Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women. J Ovarian Res. 2018;11(1):38.
   PubMedGoogle Scholar
• Le Donne M, Metro D, Alibrandi A, et al. Effects of three treatment modalities (diet, myoinositol or myoinositol associated with D-chiro-inositol) on clinical and body composition outcomes in women with polycystic ovary syndrome. Eur Rev Med Pharmacol Sci. 2019;23(5):2293–2301.
   PubMed Web of Science ®Google Scholar
• Nordio M, Basciani S, Camajani E. The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur Rev Med Pharmacol Sci. 2019;23(12):5512–5521.
   PubMed Web of Science ®Google Scholar
• Benelli E, Del Ghianda S, Di Cosmo C, et al. A combined therapy with Myo-Inositol and D-Chiro-Inositol improves endocrine parameters and insulin resistance in PCOS young overweight women. Int J Endocrinol. 2016;2016:3204083–3204085.
   PubMed Web of Science ®Google Scholar
• Monastra G, Sambuy Y, Ferruzza S, et al. Alpha-lactalbumin effect on myo-inositol intestinal absorption: in vivo and in vitro. Curr Drug Deliv. 2018;15(9):1305–1311.
   PubMed Web of Science ®Google Scholar
• Ranaldi G, Ferruzza S, Natella F, et al. Enhancement of D-chiro-inositol transport across intestinal cells by alpha-Lactalbumin peptides. Eur Rev Med Pharmacol Sci. 2020;24(19):10143–10154.
   PubMed Web of Science ®Google Scholar
• De Cicco S, Immediata V, Romualdi D, et al. Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action. Gynecol Endocrinol. 2017;33(9):698–701.
   PubMed Web of Science ®Google Scholar
• Cianci A, Panella M, Fichera M, et al. d-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS. Gynecol Endocrinol. 2015;31(6):483–486.
   PubMed Web of Science ®Google Scholar
• Laganà AS, Monti N, Fedeli V, et al. Does alpha-lipoic acid improve effects on polycystic ovary syndrome? Eur Rev Med Pharmacol Sci. 2022;26(4):1241–1247.
   PubMed Web of Science ®Google Scholar
• Lipovac M, Nairz V, Aschauer J, et al. The effect of micronutrient supplementation on spermatozoa DNA integrity in subfertile men and subsequent pregnancy rate. Gynecol Endocrinol. 2021;37(8):711–715.
   PubMed Web of Science ®Google Scholar
• Al-Bayyari N, Al-Domi H, Zayed F, et al. Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: a randomized placebo controlled clinical trial. Clin Nutr. 2021;40(3):870–878.
   PubMed Web of Science ®Google Scholar
• Unfer V. A deeper assessment of ω3-Poly-Unsaturated fatty acids in polycystic ovary syndrome management. Comment on regidor et al. Chronic inflammation in PCOS: the potential benefits of specialized Pro-Resolving lipid mediators (SPMs) in the improvement of the re. IJMS. 2021;22(18):10114.
   Google Scholar
• Nordio M. Critical considerations about the generalized use of n-3 polyunsaturated fatty acids in patients with polycystic ovary syndrome. Ann Palliat Med. 2022;11(1):407–409.
   PubMed Web of Science ®Google Scholar